AstraZeneca Cancer Drug Is First in Class, But FDA Nod Is Narrower Than Expected
The FDA approved AstraZeneca’s Truqap as a new treatment for advanced cases of breast cancer. The drug is the first in a new class of therapies addressing AKT genetic alterations.